CHU Bordeaux - Hôpital Pellegrin — Bordeaux

Public research footprint of CHU Bordeaux - Hôpital Pellegrin, compiled from the ClinicalTrials.gov public registry.

Registered studies

Active

Recruiting now

Completed

Stopped or withdrawn

Most-studied conditions

Type 1 Diabetes · Anti-Glomerular Basement Membrane Antibody Disease · Growth Hormone Deficiency · Diabetes Mellitus

Recently updated registry entries

NCT07317102 — Omnipod-5 A French Prospective Multicentric Study in Real World (Optimal-B) (Recruiting)
NCT07039942 — French Prospective Multicentric Study in Real World (Active Not Recruiting)
NCT07665554 — Advancing Neurogenetic Diagnoses Through Long-Read Sequencing (Not Yet Recruiting)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at CHU Bordeaux - Hôpital Pellegrin?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 03, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.